Evotec SE (NASDAQ:EVO – Get Free Report)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $4.57, but opened at $4.70. Evotec shares last traded at $4.67, with a volume of 13,041 shares traded.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft raised shares of Evotec from a “hold” rating to a “buy” rating in a research report on Friday, April 12th. HC Wainwright reaffirmed a “buy” rating and issued a $11.00 price objective on shares of Evotec in a research report on Thursday, May 23rd.
Evotec Stock Up 5.0 %
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. Mubadala Investment Co PJSC bought a new position in shares of Evotec during the 4th quarter valued at approximately $53,931,000. Optiver Holding B.V. boosted its holdings in Evotec by 643.1% in the 4th quarter. Optiver Holding B.V. now owns 80,810 shares of the company’s stock worth $945,000 after buying an additional 69,936 shares during the period. Cetera Advisors LLC bought a new position in Evotec in the 1st quarter worth approximately $188,000. Finally, Quadrant Capital Group LLC bought a new position in Evotec in the 4th quarter worth approximately $25,000. 5.81% of the stock is owned by institutional investors.
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Featured Stories
- Five stocks we like better than Evotec
- When to Sell a Stock for Profit or Loss
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- There Are Different Types of Stock To Invest In
- MarketBeat Week in Review – 6/24 – 6/28
- What does consumer price index measure?
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.